Extra care essential for cataract with ocular surface disease

Article

Great care and detailed assessment are essential for cataract extractions where another ocular surface disease (OSD) is present, Thomas Neuhann said. Diseases range from dry eye, conjuntivalisation, irregular surfaces and corneal scars.

Great care and detailed assessment are essential for cataract extractions where another ocular surface disease (OSD) is present, Thomas Neuhann said. Diseases range from dry eye, conjuntivalisation, irregular surfaces and corneal scars.

He said such combined presentations were rare, but they posed specific problems in the pre-, intra- and postoperative stages. In preoperative keratometry, IOL calculation is difficult and expected outcome hard to assess, while during the procedure visualisation of the capsule is problematic with an obscured cornea.

Finally, postoperative conflicts often arise between treatment of the cataract and treatment of the OSD.

During the procedure it is particularly important to take care with the capsulorhexis. "It is better to take a minute or two extra during the procedure to get it right. It's important to go very carefully," he emphasised. He added that dyes can be very useful and they are an underused resource. "If you use trypan blue it can help a lot once you've lifted the capsule," he noted.

For phaco he said it was important to ". . . err on the corneal side, if I can use that expression. You should also lift out the nucleus more than you usually do, but protect the eye with generous use of dispersing viscoelastic." Postoperatively preservative-free eye drops must also be used.

But the most important issue is to assess whether there will be any benefit for the patient. "There's no point in doing the procedure if there's little chance of improved vision for the patient," he said.

Assessing expected outcome is hard, but he recommended that surgeons try lubricating during keratometry. If it still proves impossible, surgeons should try assessment on the other eye. "Finally, if that doesn't work, try a best guess."

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.